373 related articles for article (PubMed ID: 22319445)
1. The CTLA-4 and PD-1/PD-L1 inhibitory pathways independently regulate host resistance to Plasmodium-induced acute immune pathology.
Hafalla JC; Claser C; Couper KN; Grau GE; Renia L; de Souza JB; Riley EM
PLoS Pathog; 2012 Feb; 8(2):e1002504. PubMed ID: 22319445
[TBL] [Abstract][Full Text] [Related]
2. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.
Claser C; De Souza JB; Thorburn SG; Grau GE; Riley EM; Rénia L; Hafalla JCR
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396319
[TBL] [Abstract][Full Text] [Related]
3. Neurons upregulate PD-L1 via IFN/STAT1/IRF1 to alleviate damage by CD8
Wang Y; Shen Y; Liang J; Wang S; Huang Y; Zhu Q; Zhang X; Yu K; Tong G; Yang C; Li Y; Wang J; Zhao Y
J Neuroinflammation; 2024 May; 21(1):119. PubMed ID: 38715061
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
5. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
[TBL] [Abstract][Full Text] [Related]
6. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
7. IL-12Rβ2 is essential for the development of experimental cerebral malaria.
Fauconnier M; Palomo J; Bourigault ML; Meme S; Szeremeta F; Beloeil JC; Danneels A; Charron S; Rihet P; Ryffel B; Quesniaux VF
J Immunol; 2012 Feb; 188(4):1905-14. PubMed ID: 22238458
[TBL] [Abstract][Full Text] [Related]
8. Expression of negative immune regulatory molecules, pro-inflammatory chemokine and cytokines in immunopathology of ECM developing mice.
Khandare AV; Bobade D; Deval M; Patil T; Saha B; Prakash D
Acta Trop; 2017 Aug; 172():58-63. PubMed ID: 28454880
[TBL] [Abstract][Full Text] [Related]
9. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
10. Memory CD8
Shaw TN; Haley MJ; Dookie RS; Godfrey JJ; Cheeseman AJ; Strangward P; Zeef LAH; Villegas-Mendez A; Couper KN
Immunology; 2021 Dec; 164(4):737-753. PubMed ID: 34407221
[TBL] [Abstract][Full Text] [Related]
11. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model.
Yu P; Steel JC; Zhang M; Morris JC; Waitz R; Fasso M; Allison JP; Waldmann TA
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6187-92. PubMed ID: 22474386
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria.
Ohayon A; Golenser J; Sinay R; Tamir A; Altman A; Pollack Y; Isakov N
Infect Immun; 2010 Oct; 78(10):4195-205. PubMed ID: 20660606
[TBL] [Abstract][Full Text] [Related]
15. The T-Cell Inhibitory Molecule Butyrophilin-Like 2 Is Up-regulated in Mild Plasmodium falciparum Infection and Is Protective During Experimental Cerebral Malaria.
Subramaniam KS; Spaulding E; Ivan E; Mutimura E; Kim RS; Liu X; Dong C; Feintuch CM; Zhang X; Anastos K; Lauvau G; Daily JP
J Infect Dis; 2015 Oct; 212(8):1322-31. PubMed ID: 25883389
[TBL] [Abstract][Full Text] [Related]
16. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8
Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN
Front Immunol; 2019; 10():248. PubMed ID: 30846985
[TBL] [Abstract][Full Text] [Related]
17. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
[TBL] [Abstract][Full Text] [Related]
18. PD-L1, TIM-3, and CTLA-4 Blockade Fails To Promote Resistance to Secondary Infection with Virulent Strains of Toxoplasma gondii.
Splitt SD; Souza SP; Valentine KM; Castellanos BE; Curd AB; Hoyer KK; Jensen KDC
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29967089
[TBL] [Abstract][Full Text] [Related]
19. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.
Villegas-Mendez A; Greig R; Shaw TN; de Souza JB; Gwyer Findlay E; Stumhofer JS; Hafalla JC; Blount DG; Hunter CA; Riley EM; Couper KN
J Immunol; 2012 Jul; 189(2):968-79. PubMed ID: 22723523
[TBL] [Abstract][Full Text] [Related]
20. The immunomodulatory effect of microglia on ECM neuroinflammation via the PD-1/PD-L1 pathway.
Shen Y; Li Y; Zhu Q; Wang J; Huang Y; Liang J; Wu X; Zhao Y
CNS Neurosci Ther; 2022 Jan; 28(1):46-63. PubMed ID: 34766463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
